Quick Answer
CASI Pharmaceuticals, Inc. reported Total Assets of $53.67 million for fiscal year 2024.
CASI Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $53.67M | -28.7% |
| 2023 | $75.27M | -21.8% |
| 2022 | $96.23M | -30.4% |
| 2021 | $138.30M | — |
- CASI Pharmaceuticals, Inc. showed a decrease of -28.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2024 period, CASI Pharmaceuticals, Inc.’s total assets has declined by 61.2% (from $138.30 million to $53.67 million).
- The most recent figure is from CASI Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: